Clinical Trial

Seroma of the Mammary Gland

Study acronym: SerMa
Recruiting
View on ClinicalTrials.gov →
Summary
The study is designed as international, prospective, minimal interventional study in cooperation with EUBREAST e.V. (European Breast Cancer Research Association of Surgical Trialists). Furthermore, it is planned to initiate a registry for postoperative breast seromas.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-06-01; most recent amendment 2025-02-25.
Status change: Not Yet Recruiting → Recruiting 2024-04-04
Trial Details
NCT Number NCT05899387
Lead Sponsor University Hospital Augsburg
Conditions Seroma, Breast Cancer, Mastectomy, Breast Implant; Complications
Enrollment 2,000 participants
Start Date 2024-04-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-28